-
Adults (18-64 years)
-
General population
-
Hospital
-
Monkeypox virus
-
Mpox
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
Primary care
-
SARS-CoV-2
-
Post COVID-19 condition
-
Blood sample
-
Stool sample
-
Adults (18-64 years)
-
General population
-
People at high risk of STIs
-
PrEP users
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Mpox
-
Pharmacological intervention
-
Vaccination
-
MVA-BN
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Pharmacological intervention
-
Corticosteroid
-
Methylprednisolone
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Mpox
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Blood sample
-
Stool sample
-
Adults (18-64 years)
-
People at high risk of STIs
-
Men who have sex with men
-
Hospital
-
Outpatient clinic
-
Non-hospital health centre
-
STD/STI clinic
-
Monkeypox virus
-
Mpox
-
Adults (18-64 years)
-
General population
-
Outpatient clinic
-
Non-hospital health centre
-
STD/STI clinic
-
Monkeypox virus
-
Mpox
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Immunoadsorption
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
Fragile population
-
Immunocompromised host
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Acute COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Mpox